IP Verse

Rapid Dissolution Formulation Of A Calcium Receptor Active Compound - EP3260117

PATENT ANALYSIS

Patent Details

Grant Date
Nov 27, 2019
Company
AMGEN INC.
Oppositions

ACCORD HEALTHCARE LTD

AECHTER, BERND

ARISTO PHARMA GMBH

BETAPHARM ARZNEIMITTEL GMBH

BIOGARAN

GLENMARK PHARMACEUTICALS EUROPE LTD

HGF LIMITED

PUREN PHARMA GMBH & CO. KG

TAD PHARMA GMBH

TEVA PHARMACEUTICAL INDUSTRIES LTD.

More patents of Amgen Inc.

EP4058148

EP2301961

EP2445924

Want to monitor this patent?

Feel free to send us a message here and we will get back to you